Frontlight ResearchEarly access
CompletedNo phase
Outcome of Ablation of Tachyarrhythmias in Patients With Congenital Heart Diseases
Key facts
- Who runs it
- Fayoum University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 40 people enrolled
- Started
- 16 Apr 2024
- Ended
- 28 Feb 2026
- Type of study
- Observational
- Record updated
- 8 May 2026
Who can take part
- Age
- 3 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Patients with congenital heart diseases (corrected / non corrected) with documented arrhythmia
- Patients with congenital heart diseases without documented arrhythmia but frequent palpitations
Who cannot take part
- End stage diseases e.g.: cancer stage IV
- Pregnant
- Patients with unstable hemodynamics
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Our observational study aim to to evaluate the incidence of Tachyarrhythmia in patients with congenital heart diseases (corrected/non corrected) and the effectiveness of catheter ablation.RF catheter ablation was performed to all patients and follow up for recurrence was done for one year.
The group in the trial
- Patients with congenital heart diseases with arrhythmia
Patients with congenital heart diseases (corrected / non corrected) with documented arrhythmia or without documented arrhythmia but frequent palpitations.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 8 May 2026